Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market
Holding ZBIO?
Track your performance easily

Zenas BioPharma, Inc. (ZBIO) Financial Statements

2 Followers

Zenas BioPharma, Inc. Financial Overview

Zenas BioPharma, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Zenas BioPharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -37.98M$ -27.80M$ -24.29M-
EBITDA$ -37.94M$ -27.77M$ -107.17M-
Net Income Common Stockholders$ -37.98M$ -27.80M$ -24.59M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 183.93M$ 37.15M$ 56.86M$ 72.31M
Total Assets$ 199.95M$ 49.05M$ 68.18M$ 83.79M
Total Debt$ 508.00K$ 649.00K$ 813.00K$ 964.00K
Net Debt$ -183.42M$ -36.51M$ -56.04M$ -71.35M
Total Liabilities$ 39.12M$ 51.46M$ 43.81M$ 35.94M
Stockholders Equity$ 160.83M$ -2.41M$ 24.36M$ 47.85M
Cash Flow-
Free Cash Flow$ -30.99M$ -19.12M$ 15.10B-
Operating Cash Flow$ -30.96M$ -19.10M$ 15.10B-
Investing Cash Flow$ -35.00K$ -22.00K$ -17.00K-
Financing Cash Flow$ 177.74M$ -614.00K$ -20.05B-
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

Zenas BioPharma, Inc. Debt to Assets

Zenas BioPharma, Inc. Cash Flow

Zenas BioPharma, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis